Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial membrane depolarization refers to the dissipation of the electrochemical gradient (ΔΨm) across the inner mitochondrial membrane, a critical event linked to mitochondrial dysfunction. Depolarization can be a physiological signal, such as for mitophagy—the selective removal of damaged mitochondria—or a pathological event that leads to ATP depletion, increased ROS, and apoptosis. Various drugs exploit this process for therapeutic benefit in cancer and other diseases by inducing mitochondrial dysfunction and cell death. However, mitochondrial membrane depolarization itself is a phenomenon or cellular event rather than a druggable target in the conventional sense, and its modulation can carry significant risks due to the essential roles of mitochondria in healthy tissue homeostasis.
Disruption of mitochondrial bioenergetics (inhibition of electron transport chain complexes); Induction of mitochondrial permeability transition (mPT); Generation or modulation of ROS production; Decrease in ATP synthesis; Promotion of mitophagy through PINK1/Parkin pathway; Induction of apoptosis
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial membrane depolarization.